Background:
To alleviate stinging pain in the skin entry area and visceral discomfort in patients who are undergoing ESWL.
Anesthesiology and Pain Medicine
To alleviate stinging pain in the skin entry area and visceral discomfort in patients who are undergoing ESWL.
This study was designed to investigate the effectiveness of the EMLA cream in combination with remifentanil patient-controlled analgesia (PCA) in patients undergoing ESWL treatment.
Sixty patients were divided into two double-blind randomized groups. Those in the first group were administered 3-5mm of EMLA 5% cream on a marked area; the second group received, as a placebo, a cream with no analgesic effect in the same amount. All patients were administered a remifentanil bolus with a PCA device. Arterial blood pressure, oxygen saturation, and respiratory rate were recorded throughout the procedure; postoperative side effects, agitation, and respiratory depression were measured after. Visual Analogue Scale (VAS) scores were taken preoperatively, perioperatively, directly postoperatively, and 60 minutes subsequent to finishing the procedure.
There were no statistically significant differences in the frequency of PCA demands and delivered boluses or among perioperative VAS. No significant side effects were noted. Patient satisfaction was recorded high in both groups.
EMLA cream offered no advantage over the placebo cream in patients undergoing ESWL with remifentanil PCA.
© 2013, Author(s). The Author(s) retain copyright in the Article. Upon acceptance, the Author(s) grant Brieflands the non-exclusive right of first publication and a worldwide, perpetual, royalty-free, non-exclusive license to copyedit, format, publish, reproduce, distribute, display, preserve, archive, index, promote, and make the Version of Record available in all formats and media. Brieflands and the relevant journal will be identified as the original publisher of the Version of Record. The Article will be published under the [Creative Commons Attribution 4.0 International License (CC BY 4.0)](https://creativecommons.org/licenses/by/4.0/). The Author(s) may immediately deposit and share the Version of Record in any repository or platform. No separate permission or fee is required for uses permitted under CC BY 4.0. CCC may provide optional customized reprint services.
ElGanainy E, Osman A, Elgendy H. The Efficacy and Safety of Lidocaine 1% by Local Infiltration as a Monotherapy in Extracorporeal Shock Wave Lithotripsy. Nephro-Urol Mon. 2010;2(4):. doi:
Jaffary F, Nilforoushzadeh MA, Toossi P, Zarkoob H, Shahbazi F. Topical Anesthetic Effect of EMLA and Iranian Products in Preventing Pain During Intravenous Blood Sampling Procedures: a Double-Blind Randomized Clinical Trial. J Skin Stem Cell. 2014;1(1):e16313. doi: https://doi.org/10.17795/jssc16313
kazami M. The Effect of EMLA cream on pain of venipuncture in 6-12. Med Surg Nurs J. 2014;3(2):e87914. doi:
Salar A, Kiani F, Navidian A, Mohammadi Nejad S. A Comparative Study on the Effect of EMLA Cream and Diclofenac Gel on Pain Caused by Needle Port Placement in Patients Under Chemotherapy: A Clinical Trial. Med Surg Nurs J. 2018;7(1):e79613. doi: https://doi.org/10.5812/msnj.79613
Moslemi F, Rasooli S, Baybordi A, Golzari SE. A Comparison of Patient Controlled Epidural Analgesia With Intravenous Patient Controlled Analgesia for Postoperative Pain Management After Major Gynecologic Oncologic Surgeries: A Randomized Controlled Clinical Trial. Anesth Pain Med. 2015;5(5):e29540. doi: https://doi.org/10.5812/aapm.29540
Checking
Last Update: 1 week ago
Last Update: 1 week ago
Last Update: 1 week ago
Last Update: 1 day ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):